HillelGrossmanMD

Assistant Professor, Psychiatry, Icahn School of Medicine, Mount Sinai. Co-Director, Clinical Research Core of the Alzheimer's Disease Research Center. Clinical Director of the Mount Sinai Memory and Aging Center.

Join to view full profile

Dr. Grossman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Grossman's full profile

Already have an account?

Office
James J Peters VAMC
130 West Kingsbridge Road
Bronx, NY 10468

Education & Training

Johns Hopkins UniversityResidency, Psychiatry, 1986 - 1990
University of Tennessee Health Science Center College of MedicineClass of 1986

Certifications & Licensure

NY State Medical License 1990 - 2025
MA State Medical License 1993 - 2002
MD State Medical License 1988 - 1990
American Board of Psychiatry and Neurology Psychiatry

Clinical Trials

Development of NIC5-15 in the Treatment of Alzheimer's Disease Start of enrollment: 2007 Jan 01
Completed
Phase 2
The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF) Start of enrollment: 2014 Jan 08
Completed
Phase 2, Phase 3
A Single Site, Randomized, Double-blind, Placebo Controlled Trial of NIC5-15 in Subjects With Alzheimer's Disease Start of enrollment: 2007 Apr 01
Completed
Phase 2
Phase 2 Study to Examine Grape Seed Extract as an Anti-Oligomerization Agent in Alzheimer's Disease (AD) Start of enrollment: 2018 Jul 03
Suspended
Phase 2
Join now to see all

Publications & Presentations

PubMed

2 citations
Neuropsychiatric Symptom Profile in Alzheimer's Disease and Their Relationship With Functional Decline.
Carolyn W Zhu, Lon S Schneider, Gregory A Elder, Laili Soleimani, Hillel T Grossman
The American Journal of Geriatric Psychiatry. 2024-12-01
1 citations
A Protocol for the Inclusion of Minoritized Persons in Alzheimer Disease Research From the ADNI3 Diversity Taskforce.
Ozioma C Okonkwo, Monica Rivera Mindt, Miriam T Ashford, Catherine Conti, Joe Strong
JAMA Network Open. 2024-08-01
Lessons From the Coronavirus Disease Experience: Research Participant and Staff Satisfaction With Remote Cognitive Evaluations.
Margaret Sewell, Judith Neugroschl, Carolyn W Zhu, Maria Loizos, Xiaoyi Zeng
Alzheimer Disease and Associated Disorders. 2024-02-12

Press Mentions

Associations of Regional Brain Structural Differences with Aging, Modifiable Risk Factors for Dementia, and Cognitive PerformanceDecember 2nd, 2019
Association of Altered Liver Enzymes with AD, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid BiomarkersJuly 31st, 2019

Grant Support

Phase 11-Grape Seed Extract As Anti-Oligomerization Agent In Alzheimer'S DiseaseNational Center For Complementary &Alternative Medicine2010
Development Of D-Pinitol In The Treatment Of Alzheimer'S DiseaseNational Center For Research Resources2008–2009
Alzheimer'S Disease Neuroimaging InitiativeNational Center For Research Resources2007–2008
Pilot Studies Of The Nutritional Supplement D-Pinitol In Alzheimer'S DiseaseNational Center For Complementary &Alternative Medicine2006–2008
Pilot Studies Of The Nutritional Supplement Nic5-15 In Alzheimers DiseaseNational Center For Complementary &Alternative Medicine2007
A Trial Of An Insulin-Sensitivity Enhancing Agent To Improve Cognitive OutcomNational Center For Research Resources2005
A Trial Of An Insulin-Sensitivity Enhancing Agent To Improve Cognitive Outcom...National Center For Research Resources2004